CSTL vs. LFST, SGRY, CON, PRVA, ARDT, WGS, ADUS, PACS, PGNY, and TDOC
Should you be buying Castle Biosciences stock or one of its competitors? The main competitors of Castle Biosciences include LifeStance Health Group (LFST), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), Ardent Health Partners (ARDT), GeneDx (WGS), Addus HomeCare (ADUS), PACS Group (PACS), Progyny (PGNY), and Teladoc Health (TDOC). These companies are all part of the "healthcare" industry.
Castle Biosciences vs.
LifeStance Health Group (NASDAQ:LFST) and Castle Biosciences (NASDAQ:CSTL) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, community ranking, analyst recommendations, institutional ownership and media sentiment.
Castle Biosciences has a net margin of 1.95% compared to LifeStance Health Group's net margin of -7.90%. Castle Biosciences' return on equity of 1.47% beat LifeStance Health Group's return on equity.
Castle Biosciences received 80 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 65.00% of users gave Castle Biosciences an outperform vote while only 26.19% of users gave LifeStance Health Group an outperform vote.
Castle Biosciences has lower revenue, but higher earnings than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than Castle Biosciences, indicating that it is currently the more affordable of the two stocks.
LifeStance Health Group currently has a consensus price target of $8.70, suggesting a potential upside of 8.60%. Castle Biosciences has a consensus price target of $40.29, suggesting a potential upside of 57.61%. Given Castle Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Castle Biosciences is more favorable than LifeStance Health Group.
In the previous week, Castle Biosciences had 1 more articles in the media than LifeStance Health Group. MarketBeat recorded 3 mentions for Castle Biosciences and 2 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 1.00 beat Castle Biosciences' score of 0.54 indicating that LifeStance Health Group is being referred to more favorably in the media.
LifeStance Health Group has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500. Comparatively, Castle Biosciences has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500.
85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 92.6% of Castle Biosciences shares are held by institutional investors. 6.6% of LifeStance Health Group shares are held by company insiders. Comparatively, 7.2% of Castle Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
Castle Biosciences beats LifeStance Health Group on 15 of the 18 factors compared between the two stocks.
Get Castle Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for CSTL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Castle Biosciences Competitors List
Related Companies and Tools
This page (NASDAQ:CSTL) was last updated on 1/21/2025 by MarketBeat.com Staff
Free CSTL Stock Alerts